Want to see IN:DBOL full AI Analyst Report?
Top Page
Dhampur Bio Organics Ltd
(DBOL)
Select Model
Select Model
Rating:48Neutral
Price Target:
₹122.00
▲(55.16% Upside)
Action:Reiterated
Date:05/31/26
The score is held back primarily by compressed profitability and inconsistent cash generation, alongside moderate leverage and much weaker ROE. Technicals add further pressure with bearish momentum (below 20/50DMA and negative MACD), despite near-oversold readings. Valuation is not especially supportive given the elevated P/E and only modest dividend yield.
Positive Factors
Integrated sugar-to-ethanol business model
Integrated processing supports multiple revenue streams and lets DBOL monetize sugarcane through sugar, ethanol and by-products. Captive use or sale of outputs such as bagasse and molasses can improve resource utilization and operational resilience.
Negative Factors
Severe margin compression
Thin and declining margins leave limited protection against sugarcane costs, commodity pricing changes or weaker realizations. The deterioration from prior years reduces earnings resilience and makes a modest operational or pricing setback disproportionately damaging to profit.
Read all positive and negative factors
Positive Factors
Negative Factors
Integrated sugar-to-ethanol business model
Integrated processing supports multiple revenue streams and lets DBOL monetize sugarcane through sugar, ethanol and by-products. Captive use or sale of outputs such as bagasse and molasses can improve resource utilization and operational resilience.
Read all positive factors
Dhampur Bio Organics Ltd (DBOL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹8.52B
Dividend Yield1.21%
Average Volume (3M)4.15K
Price to Earnings (P/E)9.7
Beta (1Y)0.98
Revenue Growth10.24%
EPS GrowthN/A
CountryIN
Employees1,692
SectorGeneral
Sector StrengthN/A
IndustryAgricultural Farm Products
Share Statistics
EPS (TTM)12.74
Shares Outstanding66,387,590
10 Day Avg. Volume4,096
30 Day Avg. Volume4,146
Financial Highlights & Ratios
PEG Ratio0.42
Price to Book (P/B)0.75
Price to Sales (P/S)0.36
P/FCF Ratio6.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Dhampur Bio Organics Ltd Business Overview & Revenue Model
Company Description
Dhampur Bio Organics Ltd., founded in 2020 and headquartered in New Delhi, India, functions as a holistic sugarcane processing enterprise. The company's operations in India involve the manufacturing and distribution of various products, such as re...
How the Company Makes Money
DBOL primarily makes money by selling (1) sugar and related sugar products and (2) ethanol produced through its distillery operations, with additional contributions from co-/by-products generated during sugarcane processing.
1) Sugar sales (core ...
Dhampur Bio Organics Ltd Financial Statement Overview
Summary
Income Statement
55
Neutral
Balance Sheet
58
Neutral
Cash Flow
46
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.17B | 21.09B | 18.62B | 18.39B | 24.08B | 15.54B |
| Gross Profit | 4.40B | 3.39B | 4.76B | 3.65B | 5.50B | 2.20B |
| EBITDA | 1.70B | 1.63B | 1.38B | 1.59B | 2.13B | 1.90B |
| Net Income | 839.70M | 251.80M | 146.90M | 464.90M | 1.11B | 1.02B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 23.22B | 23.98B | 23.13B | 20.77B | 20.01B |
| Cash, Cash Equivalents and Short-Term Investments | 87.10M | 361.60M | 389.80M | 293.90M | 1.04B | 229.80M |
| Total Debt | 0.00 | 10.60B | 11.62B | 10.57B | 8.10B | 8.35B |
| Total Liabilities | -10.27B | 12.95B | 13.86B | 13.01B | 10.89B | 11.23B |
| Stockholders Equity | 10.27B | 10.27B | 10.12B | 10.11B | 9.89B | 8.77B |
Cash Flow | ||||||
| Free Cash Flow | 6.69B | 1.15B | -161.70M | -2.72B | 1.45B | -4.08B |
| Operating Cash Flow | 6.89B | 1.59B | 1.30B | -1.01B | 3.55B | -2.46B |
| Investing Cash Flow | -178.20M | -422.00M | -1.46B | -1.66B | -1.96B | -1.38B |
| Financing Cash Flow | -6.52B | -1.17B | 187.90M | 1.70B | -781.20M | 3.94B |
Dhampur Bio Organics Ltd Technical Analysis
Positive
78.63
Price Trends
112.73
Positive
112.57
Positive
99.54
Positive
Market Momentum
5.39
Negative
56.80
Neutral
43.65
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DBOL, the sentiment is Positive. The current price of 78.63 is below the 20-day moving average (MA) of 118.72, below the 50-day MA of 112.73, and below the 200-day MA of 99.54, indicating a bullish trend. The MACD of 5.39 indicates Negative momentum. The RSI at 56.80 is Neutral, neither overbought nor oversold. The STOCH value of 43.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:DBOL.
Dhampur Bio Organics Ltd Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | ₹120.26B | 26.48 | ― | 1.92% | 8.58% | -1.86% | |
63 Neutral | ₹2.94B | 5.85 | ― | ― | -8.26% | 15.48% | |
56 Neutral | ₹2.46B | 8.55 | ― | ― | 16.25% | 30.77% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
48 Neutral | ₹8.52B | 9.68 | ― | 1.63% | 10.24% | ― | |
48 Neutral | ₹2.80B | 48.65 | ― | ― | -8.21% | -55.42% | |
47 Neutral | ₹51.00B | -6.40 | ― | ― | -2.60% | -96.15% |
* General Sector Average
IN:DBOL
Dhampur Bio Organics Ltd
123.73
40.24
48.20%
IN:GODREJAGRO
Godrej Agrovet Limited
614.95
-107.51
-14.88%
IN:KMSUGAR
K.M. Sugar Mills Ltd.
30.56
2.94
10.64%
IN:KOTARISUG
Kothari Sugars & Chemicals Ltd.
32.11
2.14
7.14%
IN:RENUKA
Shree Renuka Sugars Limited
23.42
-5.28
-18.40%
IN:SAKHTISUG
Sakthi Sugars Limited
19.74
-1.48
-6.97%
Dhampur Bio Organics Ltd Corporate Events
Dhampur Bio Organics files AGM voting results and scrutinizer’s report
Jul 26, 2026
Dhampur Bio Organics Limited has reported the voting results of its sixth Annual General Meeting held on July 24, 2026, conducted via video conferencing and other audio-visual means. The company submitted the consolidated scrutinizer’s repor...
Dhampur Bio Organics Posts Q1 FY27 Results, Holds Back Interim Dividend
Jul 14, 2026
Dhampur Bio Organics Ltd reported its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, following approval by the board of directors at a meeting held on July 14, 2026. The results, accompanied by a limit...
Dhampur Bio Organics Confirms Fully Dematerialized Shareholding for Q1 FY27
Jul 10, 2026
Dhampur Bio Organics Ltd. has notified the stock exchanges that it has obtained a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026, from its registrar...
Dhampur Bio Organics Completes Rs. 305 Crore Slump Sale of Meerganj Sugar Unit
Jun 18, 2026
Dhampur Bio Organics Ltd. has completed the slump sale of its Meerganj sugar unit in Bareilly, Uttar Pradesh, transferring the business as a going concern to Forever Global Enterprises Ltd. The transaction, executed under a previously announced bu...
Dhampur Bio Organics posts stronger FY26 earnings on higher revenue base
Jun 1, 2026
Dhampur Bio Organics Ltd has published its audited consolidated financial results for the quarter and year ended 31 March 2026, showing steady top-line growth and improved profitability. Total income from operations rose to ₹781.41 crore for...
Dhampur Bio Organics Discloses Resignation of Vice President for Bottling Operations
Jun 1, 2026
Dhampur Bio Organics Ltd has announced the resignation of Mr. Rakesh Agarwal from his role as Vice President – Bottling Operations, effective at the close of business on May 31, 2026. The company stated that Agarwal tendered his resignation ...
Dhampur Bio Organics Publishes Q4 and FY26 Investor Presentation
May 30, 2026
Dhampur Bio Organics Ltd has released its investor presentation for the fourth quarter and full year ended March 31, 2026, detailing the company’s financial and operational performance. The presentation, which has been shared with stock exch...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.